《Endocrine-related Cancer》雜志的最新年發文量為115篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在內分泌學與代謝領域的學術影響力。
該刊聚焦于醫學-內分泌學與代謝領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 較慢,6-12周 。
Endocrine-related Cancer 雜志發文統計
文章名稱引用次數
- Long noncoding RNAs: emerging players in thyroid cancer pathogenesis25
- Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers25
- Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial24
- Genetic testing for indeterminate thyroid cytology: review and meta-analysis22
- Anaplastic thyroid carcinoma: review of treatment protocols20
- French Endocrine Society Guidance on endocrine side effects of immunotherapy19
- Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame18
- Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study17
- Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer17
- Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives17
國家/地區發文量
- USA135
- England39
- Italy39
- CHINA MAINLAND38
- Netherlands37
- GERMANY (FED REP GER)33
- Australia26
- France26
- Canada22
- Spain18
